QV BIOELECTRONICS LTD.

Active Nether Alderley
11 employees website.com
Life sciences and medical technology
Q

QV BIOELECTRONICS LTD.

Founded 7 Oct 2018 Active Nether Alderley, England 11 employees website.com
Life sciences and medical technology

Previous Company Names

HONEYCOMB BIOTECHNOLOGY LIMITED 7 Oct 2018 — 4 Sept 2019
Accounts Due 30 Sept 2026 5 months remaining
Confirmation
Net assets £519K £728K 2024 year on year
Total assets £689K £818K 2024 year on year
Total Liabilities £171K £90K 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

21lga Alderley Park Nether Alderley Cheshire SK10 4TG England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for QV BIOELECTRONICS LTD. (11608210), an active life sciences and medical technology company based in Nether Alderley, England. Incorporated 7 Oct 2018. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£97.12k

Decreased by £816.60k (-89%)

Net Assets

£518.58k

Decreased by £727.68k (-58%)

Total Liabilities

£170.82k

Decreased by £89.95k (-34%)

Turnover

N/A

Employees

11

Decreased by 2 (-15%)

Debt Ratio

25%

Increased by 8 (+47%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 4

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Investor 2Jul 2021Seed
Investor 3Jul 2021Seed
Investor 4Jul 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 3,041,995 Shares £4.90m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Dec 2025222,218£1.62£1.62
9 Dec 2025613,166£993k£1.62
12 Sept 2025130,362£203k£1.555
12 Sept 2025307,393£478k£1.555
31 Mar 202332,452£100k£3.081

Officers

Officers

2 active 1 resigned
Status
Alastair Burns AtkinsonDirectorBritishScotland6315 Feb 2022Active
Deepak Chandulal KotakDirectorBritishEngland5930 Jun 2021Active

Shareholders

Shareholders (34)

Christopher Bullock
21.7%
600,000
Richard Zhiming Fu
14.4%
400,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Christopher John Bullock

Ceased 23 Dec 2022

Ceased

Richard Zhiming Fu

Ceased 30 Jun 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Jan 2026IncorporationMemorandum Articles
9 Jan 2026ResolutionResolutions
6 Jan 2026CapitalAllotment of shares (GBP 40.41985) on 2025-12-12
23 Dec 2025OfficersTermination of Deepak Chandulal Kotak as director on 2025-12-11
22 Dec 2025OfficersChange to director Dr Christopher John Bullock on 2025-12-01
9 Jan 2026 Incorporation

Memorandum Articles

9 Jan 2026 Resolution

Resolutions

6 Jan 2026 Capital

Allotment of shares (GBP 40.41985) on 2025-12-12

23 Dec 2025 Officers

Termination of Deepak Chandulal Kotak as director on 2025-12-11

22 Dec 2025 Officers

Change to director Dr Christopher John Bullock on 2025-12-01

Recent Activity

Latest Activity

Memorandum Articles

3 months ago on 9 Jan 2026

Resolutions

3 months ago on 9 Jan 2026

Allotment of shares (GBP 40.41985) on 2025-12-12

3 months ago on 6 Jan 2026

Termination of Deepak Chandulal Kotak as director on 2025-12-11

4 months ago on 23 Dec 2025

Change to director Dr Christopher John Bullock on 2025-12-01

4 months ago on 22 Dec 2025